Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Polyhexanide 0.005% w/v in 100 ml, 250 mL, 380 mL Solution, contact lens Sauflon Pharmaceuticals Limited, Ashford, Kent, United Kingdom All In One Amikacin sulphate equivalent to 500 mg (500 000 IU) amikacin in 2 mL Injection, vial David Bull Laboratories Limited, Mulgrave North, Victoria, Australia Amikacin Minoxidil 20 mg/mL in 60 mL Solution, topical Nu-Pharm Inc., Richmond Hill, Ontario, Canada Apo-Gain Doxorubicin hydrochloride 2 mg/mL as pegylated lyposomal doxorubicin hydrochloride in 10 mL Infusion, concentrate, vial Ben Venue Laboratories Inc., Bedford, Ohio, United States of America Caelyx Etoposide 100 mg in 5 mL Solution, infusion, vial Thissen Laboratories SA., Braine-L'Alleud, Belgium Etoposide for Injection Toremifene citrate 88.5 mg equivalent to 60 mg toremifene Tablet Orion Corporation Farmos, Turku, Finland Fareston Isosorbide mononitrate 60 mg Tablet, modified release Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia Monotrate Dornase alfa 1 mg/mL (1000 U/mL) Solution, inhaled Automated Liquid Packaging, Woodstock, Illinois, United States of America and Genentech Inc., South San Francisco, California, United States of America Pulmozyme Chlorpheniramine maleate 1 mg, dextromethorphan hydrobromide 7.5 mg, pseudoephedrine hydrochloride 15 mg per 5 mL in 25 mL, 100 mL, 200 mL Elixir Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia Robitussin Children's Night Relief Disodium tiludronate 200 mg Tablet Sanofi Winthrop Industrie, Ambares, France Skelid Stannous fluoride 0.4% w/w Gel, topical Pascal Company Inc., Bellevue, Washington, United States of America Stan-Gard (Bubblegum flavour) Stannous fluoride 0.4% w/w Gel, topical Pascal Company Inc., Bellevue, Washington, United States of America Stan-Gard (Cherry flavour) Stannous fluoride 0.4% w/w Gel, topical Pascal Company Inc., Bellevue, Washington, United States of America Stan-Gard (Mint flavour) Stannous fluoride 0.4% w/w Gel, topical Pascal Company Inc., Bellevue, Washington, United States of America Stan-Gard (Raspberry flavour) Hepatitis A inactivated virus antigen 50 U/mL in 0.5 mL, 1 mL Vaccine, injection, vial Merck & Co Inc., West Point, Pennsylvania, United States of America and Evans Medical Limited, Speke, Liverpool, England Vaqta Hepatitis A inactivated virus antigen 50 U/mL in 0.5 mL, 1 mL Vaccine, injection, pre-filled syringe Merck & Co Inc., West Point, Pennsylvania, United States of America and Evans Medical Limited, Speke, Liverpool, England Vaqta Dated this 20th day of May 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.